期刊
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
卷 295, 期 2, 页码 E297-E304出版社
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpendo.00581.2007
关键词
myogenesis; metabolism; Type 2 diabetes
资金
- NIDDK NIH HHS [P30 DK056341-08, P30 DK056341-07, P30 DK056341] Funding Source: Medline
Recent studies have shown that administration of peroxisome proliferator-activated receptor-beta (PPAR beta) agonists enhances fatty acid oxidation in rodent and human skeletal muscle and that muscle-restricted PPAR beta overexpression affects muscle metabolic profile by increasing oxidative myofiber number, which raises the possibility that PPAR beta agonists alter muscle morphology in adult animals. This possibility was examined in this study in which adult mice were treated with a PPAR beta agonist, and the resulting changes in myofiber metabolic phenotype and angiogenesis were quantified in tibialis anterior muscles. The findings indicate a muscle remodeling that is completed within 2 days and is characterized by a 1.63-fold increase in oxidative fiber number and by a 1.55-fold increase in capillary number. These changes were associated with a quick and transient upregulation of myogenic and angiogenic markers. Both myogenic and angiogenic responses were dependent on the calcineurin pathway, as they were blunted by cyclosporine A administration. In conclusion, the data indicate that PPAR beta activation is associated with a calcineurin-dependent effect on muscle morphology that enhances the oxidative phenotype.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据